Global report on primary immunodeficiencies: 2018 update from the Jeffrey Modell Centers Network on disease classification, regional trends, treatment modalities, and physician reported outcomes
- 341 Downloads
Primary immunodeficiencies (PI) are genetic defects of the immune system that result in chronic, serious, and often life-threatening infections, if not diagnosed and treated. Many patients with PI are undiagnosed, underdiagnosed, or misdiagnosed. In fact, recent studies have shown that PI may be more common than previously estimated and that as many as 1% of the population may be affected with a PI when all types and varieties are considered. In order to raise awareness of PI with the overall goal of reducing associated morbidity and mortality, the Jeffrey Modell Foundation (JMF) established a network of specialized centers that could better identify, diagnose, treat, and follow patients with PI disorders. Over the past decade, the Jeffrey Modell Centers Network (JMCN) has provided the infrastructure to accept referrals, provide diagnosis, and offer treatments. Currently, the network consists of 792 Expert Physicians at 358 institutions, in 277 cities, and 86 countries spanning 6 continents. JMF developed an annual survey for physician experts within the JMCN, using the categories and gene defects identified by the International Union of Immunological Societies Expert Committee for the Classification of PI, to report on the number of patients identified with PI; treatment modalities, including immunoglobulins, transplantation, and gene therapy; and data on gender and age. Center Directors also provided physician-reported outcomes and differentials pre- and post-diagnosis. The current physician-reported data reflect an increase in diagnosed patients, as well as those receiving treatment. Suspected patients are being identified and referred so that they can receive early and appropriate diagnosis and treatment. The significant increase in patients identified with a PI is due, in part, to expanding education and awareness initiatives, newborn screening, and the expansion of molecular diagnosis and sequencing. To our knowledge, this is the most extensive single physician report on patients with PI around the world.
KeywordsPrimary immunodeficiencies (PI) Jeffrey Modell Foundation (JMF) Jeffrey Modell Centers Network (JMCN) Awareness Education Diagnosis Treatment Gene discovery Immunology
Jeffrey Modell Foundation
Jeffrey Modell Centers Network
Severe combined immunodeficiency
International Union of Immunological Societies
Hematopoietic stem cell transplantation
Common variable immunodeficiency
Intravenous immunoglobulin therapy
Subcutaneous immunoglobulin therapy
Polyethylene glycol-conjugated adenosine deaminase
Peripheral blood stem cell
Matched unrelated donor
Mismatched unrelated donor
Matched related donor
Hospital Cost and Utilization Project
Agency for Healthcare Research and Quality
Health Care Cost Institute
The authors thank the Jeffrey Modell Center Directors for their generous support and continued commitment to the Jeffrey Modell Foundation and the global primary immunodeficiency communities. We thank Dr. Chaim Roifman, Founder, and Director of the Jeffrey Modell Centers Network, for his vision, and Dr. Jordan Orange for his expertise and guidance.
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest except for the following:
Jordan Orange, MD, PhD: Shire Consultant, Grifols Consultant, CSL consultant, received speaking honoraria from Shire, ADMA Scientific Advisory Board, author of the chapter on IVIG in Up to Date for which he receives royalties.
- 8.Stray-Pedersen A, Sorte HS, Samarakoon P, Gambin T, Chinn IK, Coban Akdemir ZH, et al. Primary immunodeficiency diseases: genomic approaches delineate heterogeneous Mendelian disorders. J Allergy Clin Immunol. 2017;139(1):232–45. https://doi.org/10.1016/j.jaci.2016.05.042.CrossRefPubMedGoogle Scholar
- 9.Rider NL, Kutac C, Hajjar J, Scalchunes C, Seeborg FO, Boyle M, et al. Health-related quality of life in adult patients with common variable immunodeficiency disorders and impact of treatment. J Clin Immunol. 2017;37(5):461–75. https://doi.org/10.1007/s10875-017-0404-8.CrossRefPubMedPubMedCentralGoogle Scholar
- 15.Picard C, Gaspar BH, Al-Herz W, Bousfiha A, Casanova JL, Chatila T, et al. International Union of Immunological Societies: 2017 primary immunodeficiency diseases committee report on inborn errors of immunity. J Clin Immunol. 2018;38(1):96–128. https://doi.org/10.1007/s10875-017-0464-9.CrossRefPubMedGoogle Scholar
- 16.Picard C, Al-Herz W, Bousfiha A, Casanova JL, Chatila T, Conley ME, et al. Primary immunodeficiency diseases: an update on the classification from the international union of immunological societies expert committee for primary immunodeficiency 2015. J Clin Immunol. 2015;35(8):696–726. https://doi.org/10.1007/s10875-015-0201-1.CrossRefPubMedPubMedCentralGoogle Scholar
- 17.Agency for Healthcare Research and Quality. http://www.hcup.ahrq.gov (2015).
- 18.Aetna Member Navigator. http://www.aetna.com (2015).
- 20.Truven Health Analytics. Healthcare Spending Index for Employer-Sponsored Insurance. 2014.Google Scholar
- 21.Centers for Medicare and Medicaid Services. Berenson-eggers type of service (BETOS). 2015. https://www.cms.gov/Medicare/Coding/HCPCSReleaseCodeSets/BETOS.html.
- 22.Centers for Medicare and Medicaid Services. Medicare current beneficiary survey (MCBS). 2015. https://www.cms.gov/Research-Statistics-Data-and-Systems/Research/MCBS/index.html?redirect=/mcbs.
- 23.Congressional Budget Office. Factors underlying the growth in medicare’s spending for physicians’ services. 2007. Retrieved 28 Apr 2010, from http://www.cbo.gov/ftpdocs/81xx/doc8193/06-06-MedicareSpending.pdf.
- 24.Fronstin P. Sources of health insurance and characteristics of the uninsured: analysis of the March 2013 current population survey, vol 390. EBRI (Employee Benefit Research Institute) Issue Brief No. 390, September 2013, Washington, DC; 2013. p. 1–36.Google Scholar
- 26.Health Care Cost Institute (HCCI) 2014 Health Care Cost and Utilization Report. 2015. http://www.healthcostinstitute.org/files/2014%20HCCUR%2010.29.15.pdf.
- 29.de la Morena MT, Leonard D, Torgerson TR, Cabral-Marques O, Slatter M, Aghamohammadi A, et al. Long-term outcomes of 176 patients with X-linked hyper-IgM syndrome treated with or without hematopoietic cell transplantation. J Allergy Clin Immunol. 2017;139(4):1282–92. https://doi.org/10.1016/j.jaci.2016.07.039.CrossRefPubMedGoogle Scholar
- 30.Merrill D. No one values your life more than the federal government. Bloomberg. October 19, 2017. https://www.bloomberg.com/graphics/2017-value-of-life/.
- 35.Pollack A. Jennifer Doudna, a Pioneer Who Helped Simplify Genome Editing. Profiles in Science, NY Times. 2015. http://www.nytimes.com/2015/05/12/science/jennifer-doudna-crispr-cas9-genetic-engineering.html?_r=0. Accessed 13 May 2015.
- 37.Naik S, Nicholas SK, Martinez CA, Leen AM, Hanley PJ, Gottschalk SM, et al. Adoptive immunotherapy for primary immunodeficiency disorders with virus-specific T lymphocytes. J Allergy Clin Immunol. 2016 May;137(5):1498–1505.e1. https://doi.org/10.1016/j.jaci.2015.12.1311.CrossRefPubMedPubMedCentralGoogle Scholar